Mobia Medical, Inc. (NASDAQ:MOBI) Receives Average Recommendation of “Moderate Buy” from Brokerages

Mobia Medical, Inc. (NASDAQ:MOBI) has received a consensus recommendation of “Moderate Buy” from the six research firms that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $20.25.

Several research firms recently issued reports on MOBI. The Goldman Sachs Group began coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They issued a “buy” rating and a $31.00 price target on the stock. Wolfe Research started coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set an “outperform” rating on the stock. Zacks Research raised shares of Mobia Medical to a “hold” rating in a report on Wednesday, June 3rd. BTIG Research started coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set a “buy” rating and a $19.00 target price on the stock. Finally, Wall Street Zen raised shares of Mobia Medical from a “sell” rating to a “hold” rating in a report on Sunday, June 14th.

Mobia Medical Stock Performance

MOBI opened at $14.63 on Friday. The firm has a market capitalization of $486.43 million, a P/E ratio of 66.00 and a beta of 2.84. Mobia Medical has a 12-month low of $10.19 and a 12-month high of $15.29.

Mobia Medical (NASDAQ:MOBI) last posted its quarterly earnings results on Thursday, June 4th. The company reported $999.00 earnings per share (EPS) for the quarter. The company had revenue of $12.07 million during the quarter.

Insider Activity at Mobia Medical

In other Mobia Medical news, CFO Nelson Bunker Curnes bought 5,000 shares of the company’s stock in a transaction on Tuesday, June 9th. The shares were bought at an average cost of $12.79 per share, with a total value of $63,950.00. Following the completion of the acquisition, the chief financial officer owned 366,997 shares of the company’s stock, valued at approximately $4,693,891.63. This trade represents a 1.38% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Cynthia L. Lucchese bought 125,000 shares of the company’s stock in a transaction on Monday, May 11th. The shares were acquired at an average cost of $15.00 per share, for a total transaction of $1,875,000.00. Following the completion of the acquisition, the director directly owned 125,000 shares of the company’s stock, valued at $1,875,000. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired 1,273,332 shares of company stock valued at $19,088,930 in the last ninety days.